Concepedia

Muthukumar Rajasekaran

MR

Statistics

Publications

4

Citations

497

H-Index

4

Active since

2016

Affiliations

Institute of Molecular and Cell Biology(Current)

Agency for Science, Technology and Research

National Cancer Centre Singapore

Duke-NUS Medical School

National University of Singapore

Muthukumar Rajasekaran is an author at Institute of Molecular and Cell Biology specializing in molecular biology, molecular oncology, and oncogenic transformation.

ORCID

Publications per year

2016–2022

4

Publications

4

The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway

Jianxiang Chen, Muthukumar Rajasekaran, Hongping Xia et al. · Gut · 2016 · 268 citations · Full text

, , +17

MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence

Hongping Xia, Shik Nie Kong, Jianxiang Chen et al. · Cancer Letters · 2016 · 123 citations · Full text

, , +15

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma

Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao et al. · Nature Communications · 2022 · 78 citations · Full text

, , +16

CDK1‐mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling

Jianxiang Chen, Muthukumar Rajasekaran, Hongping Xia et al. · The EMBO Journal · 2018 · 28 citations · Full text

, , +12

1–4 of 4